Inactive Instrument

Press Releases Diaxonhit SA Euronext Paris

Equities

ALEHT

FR0004054427

End-of-day quote Euronext Paris Other stock markets
- ^EUR	-

May. 08	Eurobio Scientific: agreement with Myriad Genetics	CF
May. 08	Eurobio Scientific to Buy Gene Expression Test for Breast Cancer	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

EUROBIO SCIENTIFIC SIGNS AN AGREEMENT TO ACQUIRE GENE EXPRESSION TEST FOR BREAST CANCER ENDOPREDICT®	May. 07	GL
EUROBIO SCIENTIFIC: 2023 ANNUAL RESULTS	Apr. 10	GL
Eurobio Scientific: FISCAL YEAR 2023, STRATEGIC TRANSFORMATION OF THE GROUP	Jan. 30	GL
Eurobio Scientific: FISCAL YEAR 2023, STRATEGIC TRANSFORMATION OF THE GROUP	Jan. 30	AQ
OSE Immunotherapeutics Announces a Collaboration Agreement with GenDx for the Development of a Companion Diagnostic for Epitope-Based Cancer Vaccine Candidate Tedopi	Nov. 22	AQ
Eurobio Scientific: CATHERINE COURBOILLET TO JOIN EUROBIO SCIENTIFIC BOARD AS AN INDEPENDENT MEMBER	Nov. 07	GL
Eurobio Scientific: CATHERINE COURBOILLET TO JOIN EUROBIO SCIENTIFIC BOARD AS AN INDEPENDENT MEMBER	Nov. 07	AQ
Interim report 1 January - 30 September 2023	Nov. 02	AQ
Eurobio Scientific - MISE À DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2023	23-10-30	GL
Eurobio Scientific - MISE À DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2023	23-10-30	AQ
Eurobio Scientific: GenDx reduces organ matching time to 3 hours	23-10-17	GL
Eurobio Scientific: GenDx reduces organ matching time to 3 hours	23-10-17	AQ
Eurobio Scientific : Results for the First Half of 2023	23-10-11	GL
Eurobio Scientific : Results for the First Half of 2023	23-10-11	AQ
Q-linea receives second ASTar order in France	23-09-28	AQ
EUROBIO : ACCELERATION OF STRATEGIC DEPLOYMENT IN THE FIRST HALF OF 2023	23-07-24	GL
EUROBIO : ACCELERATION OF STRATEGIC DEPLOYMENT IN THE FIRST HALF OF 2023	23-07-24	AQ
Interim report 1 January - 30 June 2023	23-07-13	AQ
Eurobio Scientific: Capital reduction through cancellation of treasury shares	23-07-11	GL
Eurobio Scientific: Capital reduction through cancellation of treasury shares	23-07-11	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Diaxonhit SA Euronext Paris

Equities

ALEHT

FR0004054427

Press Releases

Filters